Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Hubei Huarong Holding Co.,Ltd. is a pharmaceutical enterprise primarily engaged in the manufacturing and distribution of medicinal products across China. Its core pharmaceutical offerings notably feature Gucining Capsules and Huoxue Tongmai Capsules. Beyond its traditional drug production, the company also actively develops biological products, novel pharmaceuticals, environmental protection solutions, and agricultural goods, along with the technologies supporting these areas. The organization was formerly known as Hubei Yangfan Holding Co., Ltd. before officially adopting its current name, Hubei Huarong Holding Co.,Ltd., in November 2020. Established in 1997, the firm maintains its main operational base in Wuhan, China.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITD.